AAAAAA

   
Results: 1-14 |
Results: 14
LEARNING MODULATES CHOLINERGIC ACTIVITIES IN A MOTOR CENTER OF THE CENTER OF THE CENTRAL-NERVOUS-SYSTEM OF THE CUTTLEFISH
Authors: BELLANGER C DAUPHIN F CHICHERY MP CHICHERY R
Citation: C. Bellanger et al., LEARNING MODULATES CHOLINERGIC ACTIVITIES IN A MOTOR CENTER OF THE CENTER OF THE CENTRAL-NERVOUS-SYSTEM OF THE CUTTLEFISH, European journal of neuroscience, 10, 1998, pp. 10013-10013
RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP
Authors: BLAISE D ATTAI M REIFFERS J STOPPA AM HUGUET F MARIT G MOLINA L BELLANGER C PICO JL GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP, British Journal of Haematology, 102(1), 1998, pp. 89-89
THE USE OF A SEQUENTIAL HIGH-DOSE RECOMBINANT INTERLEUKIN-2 REGIMEN AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE THE DISEASE-FREE SURVIVAL OF PATIENTS WITH ACUTE-LEUKEMIA TRANSPLANTED IN FIRSTCOMPLETE REMISSION
Authors: BLAISE D ATTAL M PICO JL REIFFERS J STOPPA AM BELLANGER C MOLINA L NEDELLEC G VERNANT JP LEGROS M GABUS R HUGUET F BRANDELY M HERCEND T OLIVE D MARANINCHI D
Citation: D. Blaise et al., THE USE OF A SEQUENTIAL HIGH-DOSE RECOMBINANT INTERLEUKIN-2 REGIMEN AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE THE DISEASE-FREE SURVIVAL OF PATIENTS WITH ACUTE-LEUKEMIA TRANSPLANTED IN FIRSTCOMPLETE REMISSION, Leukemia & lymphoma, 25(5-6), 1997, pp. 469-478
CENTRAL ACETYLCHOLINE SYNTHESIS AND CATABOLISM ACTIVITIES IN THE CUTTLEFISH DURING AGING
Authors: BELLANGER C DAUPHIN F BELZUNCES LP CANCIAN C CHICHERY R
Citation: C. Bellanger et al., CENTRAL ACETYLCHOLINE SYNTHESIS AND CATABOLISM ACTIVITIES IN THE CUTTLEFISH DURING AGING, Brain research, 762(1-2), 1997, pp. 219-222
RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP
Authors: BLAISE D ATTAL M REIFFERS J STOPPA AM HUGUET F MARIT G MOLINA L BELLANGER C PICO JL GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP, Blood, 90(10), 1997, pp. 491-491
IN-VIVO BINDING, PHARMACOKINETICS AND METABOLISM OF THE SELECTIVE M(2) MUSCARINIC ANTAGONISTS [H-3]AF-DX-116 AND [H-3]AF-DX-184 IN THE ANESTHETIZED RAT
Authors: MICKALA P BOUTIN H BELLANGER C CHEVALIER C MACKENZIE ET DAUPHIN F
Citation: P. Mickala et al., IN-VIVO BINDING, PHARMACOKINETICS AND METABOLISM OF THE SELECTIVE M(2) MUSCARINIC ANTAGONISTS [H-3]AF-DX-116 AND [H-3]AF-DX-184 IN THE ANESTHETIZED RAT, Nuclear medicine and biology, 23(2), 1996, pp. 173-179
A PROSPECTIVE RANDOMIZED STUDY OF R-IL2 AFTER AUTOLOGUOUS BMT FOR ACUTE-LEUKEMIA IN CR-1
Authors: BLAISE D ATTAL M REIFFERS J MOLINA L BELLANGER C PICO JL NEDELEC G VERNANT JP TROUSSARD X LEGROS M GISSELBRECHT C ROSSI JF BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., A PROSPECTIVE RANDOMIZED STUDY OF R-IL2 AFTER AUTOLOGUOUS BMT FOR ACUTE-LEUKEMIA IN CR-1, Experimental hematology, 24(9), 1996, pp. 368-368
JOINT ACTION OF COMBINATIONS OF POLLUTANTS ON THE ACETYLCHOLINESTERASE ACTIVITY OF SEVERAL MARINE SPECIES
Authors: BOCQUENE G BELLANGER C CADIOU Y GALGANI F
Citation: G. Bocquene et al., JOINT ACTION OF COMBINATIONS OF POLLUTANTS ON THE ACETYLCHOLINESTERASE ACTIVITY OF SEVERAL MARINE SPECIES, Ecotoxicology, 4(4), 1995, pp. 266-279
THE ESO-SCULPTOR FAINT GALAXY REDSHIFT SURVEY - THE SPECTROSCOPIC SAMPLE
Authors: BELLANGER C DELAPPARENT V ARNOUTS S MATHEZ G MAZURE A MELLIER Y
Citation: C. Bellanger et al., THE ESO-SCULPTOR FAINT GALAXY REDSHIFT SURVEY - THE SPECTROSCOPIC SAMPLE, Astronomy & Astrophysics. Supplement series, 110(1), 1995, pp. 159-171
LEUKEMIA-FREE SURVIVAL AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY INTERLEUKIN-2 IN 50 PATIENTS WITH ACUTE-LEUKEMIA IN FIRST REMISSION
Authors: BLAISE D ATTAL M PICO JL REIFFERS J STOPPA AM BELLANGER C MOLINA L NEDELEC G VERNANT JM LEGROS M GABUS R HUGUET F BRANDELY M HERCEND T OLIVE D MARANINCHI D
Citation: D. Blaise et al., LEUKEMIA-FREE SURVIVAL AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY INTERLEUKIN-2 IN 50 PATIENTS WITH ACUTE-LEUKEMIA IN FIRST REMISSION, Blood, 86(10), 1995, pp. 364-364
MAPPING THE GALAXY DISTRIBUTION AT LARGE DISTANCES
Authors: BELLANGER C DELAPPARENT V
Citation: C. Bellanger et V. Delapparent, MAPPING THE GALAXY DISTRIBUTION AT LARGE DISTANCES, The Astrophysical journal, 455(2), 1995, pp. 103-107
GVHD PROPHYLAXIS WITH AN ANTI-IL2 RECEPTOR MONOCLONAL-ANTIBODY - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL IN STANDARD RISK LEUKEMIA
Authors: BLAISE D OLIVE D ARCHIMBAUD E REIFFERS J LEBLOND V MICHALLET M VERNANT JP IFRAH N BELLANGER C ATTAL M MILPIED N MARIT G GUYOTAT D CAUDRELIER P HIRN M MARANINCHI D
Citation: D. Blaise et al., GVHD PROPHYLAXIS WITH AN ANTI-IL2 RECEPTOR MONOCLONAL-ANTIBODY - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL IN STANDARD RISK LEUKEMIA, Blood, 84(10), 1994, pp. 10000539-10000539
AUTO BMT FOLLOWED BY RECOMBINANT IL2 (RIL2) IN 41 PATIENTS WITH CR-1 ACUTE-LEUKEMIA
Authors: BLAISE D STOPPA AM OLIVE D ATTAL M PICO JL BELLANGER C REIFFERS J LEGROS M MICHALLET M GABUS R BRANDELY M MARANINCHI D
Citation: D. Blaise et al., AUTO BMT FOLLOWED BY RECOMBINANT IL2 (RIL2) IN 41 PATIENTS WITH CR-1 ACUTE-LEUKEMIA, Experimental hematology, 21(8), 1993, pp. 1115-1115
RAT INVIVO BINDING AND PHARMACOKINETIC PROFILE OF [H-3] AF-DX 116, A SELECTIVE M2 MUSCARINIC RECEPTOR ANTAGONIST
Authors: DAUPHIN F BELLANGER C MICKALA P DUVAL D MACKENZIE ET
Citation: F. Dauphin et al., RAT INVIVO BINDING AND PHARMACOKINETIC PROFILE OF [H-3] AF-DX 116, A SELECTIVE M2 MUSCARINIC RECEPTOR ANTAGONIST, The Journal of nuclear medicine, 34(5), 1993, pp. 243-243
Risultati: 1-14 |